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Abstract. 
 
Phosphatidylinositol 3-kinase (PI3K) has 
been shown to be an important mediator of intracellu-
lar signal transduction in mammalian cells. We show 
here, for the first time, that the blockade of PI3K activ-
ity in human fetal undifferentiated cells induced mor-
phological and functional endocrine differentiation. 
This was associated with an increase in mRNA levels of 
insulin, glucagon, and somatostatin, as well as an in-
crease in the insulin protein content and secretion in re-
sponse to secretagogues. Blockade of PI3K also in-
creased the proportion of pluripotent precursor cells 
coexpressing multiple hormones and the total number 
of terminally differentiated cells originating from these 
precursor cells. We examined whether any of the re-
cently described modulators of endocrine differentia-
tion could participate in regulating PI3K activity in fe-
tal islet cells. The activity of PI3K was inversely 
correlated with the hepatocyte growth factor/scatter 
factor–induced downregulation or nicotinamide-
induced upregulation of islet-specific gene expression, 
giving support to the role of PI3K, as a negative regula-
tor of endocrine differentiation. In conclusion, our re-
sults provide a mechanism for the regulation of hor-
mone-specific gene expression during human fetal 
neogenesis. They also suggest a novel function for 
PI3K, as a negative regulator of cellular differentiation.
 
T
 
he
 
 identification of mechanisms involved in the for-
mation and function of the mammalian endocrine
system is one of the most important issues in devel-
opmental biology. The differentiation and growth of endo-
crine organs can be regulated at several levels. One level is
the regulation of reactions controlled by intracellular sig-
nal messengers. This type of regulation provides a differ-
ent gene expression response to various external stimuli,
which is critical for rates of hormone biosynthesis and re-
lease.
Phosphatidylinositol 3-kinase (PI3K)
 
1
 
 is a ubiquitous
enzyme that has been shown to be an important mediator
of intracellular signaling in mammalian cells. To date, the
expanding family of mammalian PI3K consists of three
members, each containing a different p110 catalytic sub-
unit (Hiles et al., 1992; Hu et al., 1993; Stoyanov et al., 1995).
Upon activation, PI3K phosphorylates inositides at the D-3
position of the inositol ring to generate such lipid messen-
gers as: PtdIns(3)P, PtdIns(3,4)P
 
2
 
, and PtdIns(3,4,5)P
 
3
 
 (see
abbreviations footnote for explanation of nomenclature).
The exact role and downstream molecular targets of these
lipid products are unknown. However, it is known that
overall increases in the levels of these messengers corre-
lates with mitogenic signaling by growth factors (Cantley
et al., 1991), secretion, and vesicle trafficking (Brown et al.,
1995), as well as chemotaxis, cell shape changes, and mem-
brane ruffling (Traynor-Kaplan et al., 1988; Eberle et al.,
1990; Wennstrom et al., 1994). PI3K was reported to be
important for the regulation of insulin receptor-induced in-
tracellular pathways, including glucose transport (Backer
et al., 1993). Similarly, members of the seven transmem-
brane-spanning receptor family, hormone and sensory re-
ceptor system in mammalian cells, were recently shown to
use PI3K to transduce signals to the interior of the cell and
to assemble the ras activation complex (Ptasznik et al.,
1995, 1996; Touhara et al., 1995). Several studies have
shown that the PI3K lipid products are signaling interme-
diates in the induction of cellular differentiation of PC12
pheochromocytoma cells (Hempstead et al., 1992; Kimura
et al., 1994) as well as of adipocytic 3T3-F442A cells (Saad
et al., 1994), suggesting that this enzyme may function as a
positive regulator of cellular differentiation in these cell
lines.
While the process of endocrine cell differentiation has
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1. 
 
Abbreviations used in this paper
 
: HGF/SF, hepatocyte growth factor/
scatter factor; ICC, islet-like cell cluster; NIC, nicotinamide; PI3K, phos-
phatidylinositol 3-kinase; PI, phosphatidylinositol; PIP, phosphatidylinosi-
tol 4 phosphate; PIP
 
2
 
, phosphatidylinositol 4,5 bisphosphate; PIP
 
3
 
 or
Pt-dIns(3,4,5)P
 
3
 
, phosphatidylinositol 3,4,5 trisphosphate; PKC, protein
kinase C; PtdIns(3)P, phosphatidylinositol 3 phosphate; PtdIns(3,4)P
 
2
 
,
phosphatidylinositol 3,4 bisphosphate.
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been extensively studied, no specific intracellular signaling
pathway directly involved in regulating expression of en-
docrine-specific genes has been identified. Because of the
role of PI3K in mitogenesis, differentiation, and stimulus-
secretion pathways, we have investigated the possibility
that this enzyme regulates endocrine differentiation in
mammalian cells. Until recently, most of the studies ad-
dressing the role of PI3K in cellular proliferation and dif-
ferentiation were undertaken using a variety of cell lines
and transfection methodologies. Such transformed cells
are capable of indefinite replication in culture and express
only some of the differentiated properties of their cell of
origin. Thus, these approaches provide only limited infor-
mation about the potential link between PI3K activity and
development. With the identification of the drugs wort-
mannin (Powis et al., 1994) and Ly294002 (Vlahos et al.,
1994) as potent PI3K inhibitors, it became possible to di-
rectly inhibit the endogenous PI3K activity in cultured pri-
mary cells. In the present experiments, we have used, as a
model for endocrine differentiation, human fetal–derived
pancreatic cells, growing in vitro as islet-like cell clusters
(ICCs) (Sandler et al., 1989). The cellular composition of
ICCs consists mostly of undifferentiated epithelial cells
(
 
z
 
80%) containing putative precursors of the hormone-
producing cells (Sandler et al., 1989; Otonkoski et al.,
1993; Beattie et al., 1994). Endocrine cells developing in
vitro within ICCs originate from undifferentiated, pluripo-
tent epithelial cells and contain insulin-producing 
 
b
 
 cells
and the three other cell types, 
 
a
 
, 
 
d
 
, and pp, secreting gluca-
gon, somatostatin, and pancreatic polypeptide, respec-
tively. An advantage of this model system is the ability to
mimic steps of the differentiation process in cell culture, as
evidenced by the fact that after being transplanted into
athymic nude mice, ICCs develop into morphologically
and functionally mature endocrine tissue (Sandler et al.,
1985; Beattie et al., 1994).
We now report that wortmannin or Ly294002 blockade
of PI3K activity significantly increased the number of hor-
mone-producing cells growing in ICCs. These unexpected
results indicate that PI3K plays a role as a negative regula-
tor of cellular differentiation during fetal neogenesis of en-
docrine system.
 
Materials and Methods
 
Tissue Culture
 
The use of human fetal tissue for these studies was reviewed and approved
by the Institutional Review Board at our university. Human fetal pancre-
ases at 18–24 gestational wk were obtained with appropriate permissions
and patient consent through nonprofit organ procurement programs (Ad-
vanced Bioscence Resources, Oakland, CA; Anatomic Gift Foundation,
Laurel, MD). Experiments were started by the enzymatic digestion with
collagenase P (Boehringer Mannheim Corp., Indianapolis, IN) of the hu-
man fetal pancreases followed by tissue culture for 5 d, which led to the
formation in vitro of ICCs, as previously described in detail (Otonkoski et al.,
1993). The cells, cultured for 5 d, were treated continuously with 10 
 
m
 
M
Ly294002 (Calbiochem Corp., La Jolla, CA), 100 nM wortmannin (Sigma
Chemical Co., St. Louis, MO), 10 mM nicotinamide (NIC) (Sigma Chemi-
cal Co.), or 25 ng/ml hepatocyte growth factor/scatter factor (HGF/SF) (a
kind gift of J.S. Rubin, National Cancer Institute, Bethesda, MD). These
concentrations of wortmannin and Ly294002 were found to be effective in
inhibiting PI3K activity in our preliminary, dose-response experiments.
The effective doses for NIC and HGF/SF as modulators of endocrine dif-
ferentiation in fetal islet cells were established in our laboratory previ-
ously (Otonkoski et al., 1993; Beattie et al., 1996
 
a
 
). PI3K inhibitors, NIC,
or HGF/SF was added to the culture medium from the very beginning.
Medium plus factor was changed every day for 5 d. For direct comparison,
portions of the same pancreases were grown, treated with factors, and
used for transcriptional analyses, insulin content and secretion, PI3K ac-
tivities, and DNA synthesis.
 
Isolation of Fetal Pancreatic Islets
 
Effects of PI3K inhibitors on endocrine function were tested not only in
ICCs, but also in purified islets. Undifferentiated epithelial cells account
for 
 
z
 
75–80% of the total cell mass in ICCs. By contrast, purified fetal is-
lets contain about 10-fold fewer undifferentiated epithelial cells (Beattie
et al., 1996
 
b
 
). Purification of human fetal pancreatic islets was performed
as recently described (Beattie et al., 1996
 
b
 
). Fetal islets, identified as ho-
mogeneous differentiated clusters of dithizone-positive cells, were incu-
bated with factors as above.
 
RNA Isolation and Analysis
 
Transcriptional analyses on total RNA (0.5 
 
m
 
g) were performed using a
multiprobe ribonuclease protection assay, as previously described (Oton-
koski et al., 1993). The housekeeping gene cyclophilin was used as an in-
ternal control, and yeast tRNA (10 
 
m
 
g) was included as a negative control.
Probes used were of human origin and were described previously (Oton-
koski et al., 1993). Target RNAs were quantitated in autoradiographs by
scanning densitometry (LKB UltroScan XL Laser) and integrated using
Gel Scan XL software (Pharmacia LKB Biotechnology, Inc., Piscataway,
NJ). The probe-specific mRNA signals were normalized to the cyclophilin
signal in each sample to account for differences in sample loading between
lanes.
 
Insulin Content, Insulin Secretion, and DNA Synthesis
 
After incubation with various factors in culture, the ICCs were harvested,
and measurements of insulin content, insulin release in response to glu-
cose plus theophylline, and [
 
3
 
H]thymidine incorporation into DNA were
performed as described previously (Otonkoski et al., 1993).
 
PI3K Assay
 
Aliquots of cell lysates normalized for protein content were incubated for
3 h with anti-PI3K antibodies directed against the 85-kD regulatory sub-
unit or with antiphosphotyrosine antibodies (Upstate Biotechnology, Inc.,
Lake Placid, NY). The immune complexes were absorbed onto protein
A–Sepharose and washed as described (Ptasznik et al., 1995). PI3K assays
were performed directly on beads. Briefly, the reaction was carried out for
10 min in a buffer containing 40 mM Hepes, pH 7.2, 6 mM MgCl
 
2
 
, 1 mM
EDTA, 10 
 
m
 
g of PI (Avanti Polar Lipids, Alabaster, AL), 10 
 
m
 
M ATP,
and 10 
 
m
 
Ci [
 
g
 
-
 
32
 
P]ATP (6,000 Ci/mmol; DuPont/NEN, Wilmington, DE).
Adenosine (0.2 mM) was added to the reaction mixture to inhibit residual
PI
 
4
 
-kinase activity. After the incubation, the reaction was stopped with
methanol plus 2.4 N HCl (1:1, vol/vol), and lipids were extracted, analyzed
by thin-layer chromatography, and quantified as described previously
(Ptasznik et al., 1995). In some experiments, the direct binding of PI3K to
p190Met after HGF/SF stimulation of islet cells was determined, as previ-
ously described in detail (Graziani et al., 1991).
 
Determination of Total Cellular PIP
 
3
 
The ICCs, which were pretreated for 5 d with PI3K inhibitors, NIC, HGF/
SF, or control buffer, were subsequently harvested and suspended at a
concentration of 2 
 
3
 
 10
 
5
 
 cells/ml in buffer A (30 mM Hepes, pH 7.2, 110 mM
NaCl, 10 mM KCl, 1 mM MgCl
 
2
 
, 10 mM glucose), and 1 mCi/ml [
 
32
 
P]or-
thophosphate (HCl-free; DuPont/NEN) was added. The cells were incu-
bated at 37
 
8
 
C for 2 h and then washed 3
 
3
 
 with buffer A. Depending on
the type of experiment, the labeled islet cells were either directly lysed by
addition of 3 ml chloroform/methanol (1:2, vol/vol), followed by 4 ml chlo-
roform/2.4 M HCl (1:1, vol/vol) (to measure basal levels of PIP
 
3
 
), or la-
beled cells were first stimulated with 25 ng/ml HGF/SF for the indicated
times, and subsequently the reaction was stopped as above (to measure
the inducible levels of PIP
 
3
 
). Phospholipids were extracted and analyzed
by thin-layer chromatography, and the total cellular PIP
 
3
 
 was quantified,
as we described previously in detail (Ptasznik et al., 1996). 
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Triple Immunofluorescence and Confocal Microscopy
 
ICCs cultured for 5 d in either control medium or medium containing 10
 
m
 
M Ly294002 were paraffin embedded, and 5-
 
m
 
m sections were stained
for hormone immunoreactivity. To simultaneously identify cells producing
insulin, glucagon, somatostatin, and pancreatic polypeptide (pp), we fol-
lowed a modification of our previous protocol for multiple labeling (Oton-
koski et al., 1996). Briefly, sections were incubated for 1 h at room tem-
perature with a mixture of primary antibodies: IgG fraction of a sheep
anti–human insulin antiserum (The Binding Site, Birmingham, England)
(5 
 
m
 
g/ml), mouse monoclonal anti–human glucagon (Sigma Chemical Co.)
(1 
 
m
 
g/ml), rabbit anti–human somatostatin antiserum (Dako Corporation,
Carpinteria, CA) (used at 1:100 dilution), and rabbit anti–human pp anti-
serum (Chemicon International, Inc., Temecula, CA) (used at 1:100 di-
lution). In separate sections, a mixture of normal sheep, rabbit, and mouse
IgGs was used as control reference for specificity of primary antibodies.
After washings in PBS-DS (5 mM glycine, 0.2% donkey serum, 0.1% BSA),
sections were incubated for 1 h at room temperature with a cocktail of
F(ab
 
9
 
)
 
2
 
 fractions from secondary antibodies: lissamine-rhodamine–conju-
gated affinity-purified donkey anti–sheep IgGs (5 
 
m
 
g/ml); FITC-conju-
gated affinity-purified donkey anti–rabbit IgGs (5 
 
m
 
g/ml); and indodicar-
bocyanine-conjugated affinity-purified donkey anti–mouse IgGs (5 
 
m
 
g/ml).
All F(ab
 
9
 
)
 
2
 
 were preadsorbed on appropriate multiple species to eliminate
the possibility of cross-reactivity in multiple labeling protocols (Jackson
ImmunoResearch Labs, Inc., West Grove, PA). The sections were pro-
cessed as previously described (Otonkoski et al., 1996) and viewed on a la-
ser scanning confocal microscope (model MRC-1024; BioRad Laborato-
ries, Hercules, CA).
 
Morphometric Analysis and Statistics
 
Sections were prepared from control and Ly294002-treated ICCs from
three independent experiments. After immunostaining, confocal images
were acquired from 57 control and 61 Ly294002-treated ICC sections. All
images collected (one image per section) were then analyzed for total sur-
face area and insulin-, glucagon-, somatostatin-, and pp-positive cell sur-
face area by using measurement tools in the software NIH Image 1.60
(National Institutes of Health, Bethesda, MD). Data were analyzed in Stat
View 4.01 (Abacus Concepts, Inc., Berkeley, CA) for calculation of mean,
standard deviation, and parametric statistic (
 
t
 
 test).
 
Results
 
Inhibition of PI3K Increases Islet-specific Hormone 
Biosynthesis and Hormone Secretion in Developing 
Fetal Pancreatic Cells
 
To investigate whether PI3K activation is important for
endocrine differentiation of human fetal pancreatic cells,
we continuously treated ICCs for 5 d with 100 nM wort-
mannin or 10 
 
m
 
M Ly294002, concentrations that block over
90% of total PI3K activity in intact fetal islet cells (data not
shown; see Fig. 7). We established that these concentra-
tions of wortmannin and Ly294002 almost completely in-
hibited the rise in PIP
 
3
 
 formation stimulated by growth
factors in intact [
 
32
 
P]orthophosphate-labeled islet cells.
By contrast, these concentrations of inhibitors did not af-
fect significantly the ratio of [
 
32
 
P]PIP
 
2
 
 to [
 
32
 
P]PIP and
[
 
32
 
P]PIP to [
 
32
 
P]PI in phospholipid labeling experiments
where PIP
 
3
 
 levels were measured, implying that other ki-
nases (PI5K and PI4K) were not inhibited under these
conditions. Wortmannin, a fungal metabolite, functions as
a covalent inhibitor of the catalytic p110 subunits of PI3Ks
at nanomolar concentrations, whereas Ly294002, a struc-
turally and mechanistically distinct compound, functions
as a noncovalent, competitive inhibitor of PI3Ks at 100-
fold higher concentrations than wortmannin (Okada et al.,
1994; Powis et al., 1994; Vlahos et al., 1994; Wymann et
al., 1996). At nanomolar concentrations, wortmannin is
thought to be selective for PI3K. Ly294002, even at micro-
molar concentrations, is quite specific for PI3K and does
not affect PI4K or a number of intracellular Ser/Thr and
Tyr kinases (Vlahos et al., 1994). Finally, we have also
shown that continuous treatment for 5 d with 100 nM wort-
mannin or 10 
 
m
 
M Ly294002 does not cause notable cyto-
toxity nor induce apoptosis in fetal pancreatic cells grow-
ing as islet-like cell clusters (data not shown).
We measured the transcriptional expression of islet-spe-
cific hormone genes in ICCs growing for 5 d in the pres-
ence of PI3K inhibitors. As shown in Fig. 1, wortmannin
and Ly294002 increased the transcriptional levels of insu-
lin, glucagon, and somatostatin in cells within the ICCs.
The pattern of alterations of mRNA levels was strikingly
similar to that of insulin protein (see below). Therefore,
these data indicate that two structurally distinct com-
pounds have similar effects on hormone transcription as a
consequence of their shared ability to function as specific
inhibitors of PI3K. The inhibitors had no effects on cyclo-
philin mRNA, which was used as an internal control. The
quantitative analysis of islet hormone transcription levels,
after normalization to cyclophilin expression, is shown in
Fig. 1 
 
C.
 
 To better understand the effect of these PI3K in-
hibitors on islet hormone gene expression, we have com-
pared the effect of PI3K inhibitors alone to the NIC-induced
increase in expression of islet-specific hormone genes
(Otonkoski et al., 1993). NIC is an inhibitor of the enzyme
poly(ADP-ribose) synthetase and can potently induce hu-
man fetal islet cell differentiation by influencing the tran-
scription of DNA (Yonemura et al., 1984; Sandler et al.,
1989). Treatment with the combination of a PI3K inhibi-
tor and NIC resulted in a synergistic increase in mRNA
levels of islet-specific hormones (maximum increase is
about 10-fold for insulin and somatostatin, and fourfold
for glucagon). Taken together, these data suggest that PI3K
is a negative regulator of islet-specific gene expression in
developing pancreatic cells.
We also measured the insulin content and insulin sec-
retion per cellular DNA in fetal ICCs cultured for 5 d in
the presence of the PI3K inhibitors. As shown in Fig. 2, 
 
A
 
and 
 
B
 
, we found that both insulin content and secretion
were significantly increased in Ly294002-treated cells, as
compared to untreated control cells. Wortmannin also in-
duced increases in these parameters, but to a lesser extent.
(Wortmannin appears to be a much less stable agent than
Ly294002 in culture medium [Kimura at al. 1994] [data not
shown].) The pattern of alterations of insulin secretion was
almost identical to that of insulin content, indicating a close
functional association between these two parameters. This
would suggest that a continuous blockade of PI3K activity
could secondarily increase insulin secretion through po-
tent stimulation of insulin biosynthesis in developing islet
cells. Consistent with this, we observed no direct effect of
PI3K inhibitors on insulin secretion when islet cells were
treated with these inhibitors for a short time (0.5 and 2 h;
data not shown). No significant differences were observed
in insulin content under these conditions. The observation
that short-term inhibition of PI3K does not significantly
affect insulin secretion was also recently shown in rat islets
and insulin-secreting 
 
b
 
-TC3 cells and has already been ex-
haustively discussed by other investigators (Gao et al.,
1996). Taken together, these data suggest that the continu- 
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ous blockade of PI3K activity triggered changes in mRNA
levels and that these changes were followed by a signifi-
cant increase in hormone biosynthesis and a subsequent
increase in hormone secretion.
To determine whether PI3K inhibitors increase the pro-
portion of islet cells expressing hormones, confocal immu-
nofluorescent detection of all islet-specific hormones, fol-
lowed by morphometric analysis of the ICCs, was carried
out. Fig. 3 shows representative fields of a microscopic
analysis performed on sections from human fetal ICCs,
cultured with or without Ly294002 for 5 d. Only a few hor-
mone-positive cells were visible in ICCs cultured in con-
trol medium. By contrast, hormone-positive cells were more
common in ICCs cultured with the PI3K inhibitor (4.4-fold
increase in the total percentage of endocrine-positive cells
in Ly294002-treated ICCs, as compared to control ICCs).
Interestingly, in Ly294002-treated ICCs, we detected more
cells positive for more than one protein, indicating that the
PI3K inhibitor can trigger activation of multiple hormone-
specific genes in a single cell. It was previously shown that
coexpression of multiple hormones represents an early step
in the endocrine differentiation program of islet cell pro-
genitors (Alpert et al., 1988; Herrera et al., 1991). The present
results thus suggest that PI3K inhibitors induce a process
of endocrine differentiation in fetal islet precursor cells.
 
Inhibition of PI3K Decreases DNA Synthesis in Fetal 
Pancreatic Cells
 
We measured DNA synthesis in fetal ICCs cultured in the
presence of the PI3K inhibitors. As shown in Fig. 4 
 
A
 
, wort-
mannin and Ly294002 significantly decreased the [
 
3
 
H]thy-
midine incorporation into DNA in cells within the ICCs.
Treatment with the combination of the PI3K inhibitor and
NIC resulted in a synergistic decrease in DNA synthesis.
To make certain that the observed increase in islet-specific
hormone expression in PI3K inhibitor–treated cells is not
secondary to nonspecific blockade of the cell cycle, we mea-
sured insulin protein expression in mitomycin C–treated
or serum-starved cells. As shown in Fig. 4, 
 
B
 
 and 
 
C
 
, nei-
ther mitomycin C–induced blockade of DNA synthesis nor
 
Figure 1.
 
Stimulatory effect of PI3K inhibitors on islet hormone
gene expression. Total RNA from ICCs cultured for 5 d was hy-
bridized simultaneously to radiolabeled antisense riboprobes for
(
 
A
 
) glucagon (
 
Glu
 
), insulin (
 
Ins
 
), and cyclophilin (
 
Cyclo
 
), or (
 
B
 
)
somatostatin (
 
Som
 
) and cyclophilin (
 
Cyclo
 
). Protected fragments
for glucagon (389 nucleotides), insulin (262 nucleotides), somato-
statin (206 nucleotides), and cyclophilin (135 nucleotides) are in-
dicated. Lanes: 
 
CONT
 
, control ICCs; 
 
NIC
 
, 
 
W
 
, and 
 
LY
 
, ICCs cul-
tured in the presence of nicotinamide, wortmannin, or Ly294002,
respectively; 
 
NIC
 
1
 
W
 
 or 
 
NIC
 
1
 
LY
 
, ICCs cultured in the presence
of the combination of nicotinamide and either wortmannin or
Ly294002; 
 
tRNA
 
, yeast tRNA (10 
 
m
 
g) used as a negative control;
 
P
 
, mixture of undigested probes (from top: [
 
A
 
] glucagon, insulin,
cyclophilin; [
 
B
 
] somatostatin, cyclophilin); 
 
M
 
, RNA molecular size
markers, in nucleotides (Ambion, Inc., Austin, Texas). (
 
C
 
) Quan-
titative analysis of hormone transcription levels. Densitometri-
cally determined band intensities of target mRNAs are shown af-
ter normalization to the cyclophilin signal from the RNase
protection assays shown in 
 
A
 
 and 
 
B.
 
 Values are compared to the
control samples. Results shown are representative of two inde-
pendent experiments. 
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serum starvation affected insulin protein expression in
ICCs. Consistent with this observation, neither mitomycin
C, which is known to interact directly with DNA (Tomasz
et al., 1987), nor serum starvation significantly affected
basal PI3K activity in fetal islet cells (data not shown).
Thus, the stimulatory effect of PI3K inhibitors on endo-
crine differentiation is not secondary to blockade of cell
proliferation but is due to the specific blockade of PI3K.
 
HGF/SF or NIC-dependent Regulation of Endocrine 
Differentiation Is Inversely Related to PI3K Activity
 
To clarify the correlation between PI3K activity and endo-
crine-specific gene expression, we examined whether any
of the recently described modulators of endocrine differ-
entiation could participate in regulating PI3K activity in is-
let cells. Mesenchyme-derived HGF/SF is a physiological
modulator of endocrine differentiation in human fetal islet
cells. When fetal ICCs were induced to proliferate by the
addition of HGF/SF, a marked downregulation of both in-
sulin and glucagon gene transcription, as well as insulin
protein biosynthesis, was observed (Beattie et al., 1996
 
a
 
;
Otonkoski et al., 1996). By contrast, addition of NIC un-
der the same conditions resulted in an increase in insulin
and glucagon mRNA levels and insulin protein biosynthe-
sis. These data indicate a role for HGF/SF in promoting
proliferation and inhibiting the endocrine function of fetal
islet cells. The HGF/SF receptor is known to function by
activating PI3K in a variety of cellular systems (Graziani
et al., 1991). Consistent with this, cellular PI3K is robustly
activated in fetal islet cells after acute HGF/SF stimula-
tion, and this activation results from direct binding of
PI3K to the HGF/SF receptor (Fig. 5 and data not shown).
Similarly, analysis of [
 
32
 
P]orthophosphate-labeled ICCs,
growing continuously in the presence of HGF/SF, showed
a threefold increase in levels of the major lipid product of
PI3K; PIP
 
3
 
 (Fig. 6). Thus, the HGF/SF-triggered downreg-
ulation of hormone-specific genes is associated with an in-
crease in proliferation of islet cells and with an increase of
PI3K activity.
In contrast to HGF/SF, NIC is known to increase both
insulin content and insulin release in ICCs (Sandler et al.,
1989), as well as to upregulate the expression of islet-spe-
cific hormone genes (Otonkoski et al., 1993). Fig. 7 shows
the amount of PI3K activity measured in p85 subunit anti-
body immunoprecipitates from control, NIC-treated, and
PI3K inhibitor–treated fetal ICCs. A significantly lower
(about fivefold) amount of PI3K activity was present in
p85 immunoprecipitates from NIC-treated cells, as com-
pared to untreated cells. We consistently observed that the
basal level of PIP
 
3
 
 was significantly lower in NIC-treated
ICCs than in control cells (Fig. 6). Treatment with wort-
mannin or Ly294002 eliminated 
 
.
 
90% of control PI3K ac-
tivity under these conditions (Fig. 7). Inducibility of cellu-
lar PI3K activity by growth factors, as well as the de novo
formation of PIP
 
3
 
, was significantly reduced in NIC-treated
cells. There was no change in the actual level of p85 pro-
tein during NIC treatment, as determined by Western
blotting, nor was there a direct inhibitory effect of various
concentrations of NIC on PI3K activity in vitro in p85 im-
munoprecipitates, indicating that NIC is not a direct inhib-
itor of PI3K (data not shown). The mechanism by which
NIC attenuates cellular PI3K activity in developing fetal
islet cells remains to be determined. The cell culture and
treatment conditions used in Fig. 7 were identical to those
used in Fig. 1 and Fig. 2, indicating that an inverse correla-
tion exists between the amount of PI3K activity and the
stage of endocrine maturity in islet cells during fetal neo-
genesis.
 
Discussion
 
The cellular signaling pathways that are required for endo-
crine differentiation are unknown. The present studies
clearly indicate that lipid products of PI3K are an impor-
tant part of the regulatory network that links differentia-
Figure 2. Stimulatory effects of PI3K inhibitors on insulin con-
tent and insulin secretion in fetal islet cells. Replicate groups of
50 human fetal ICCs were cultured for 5 d in the presence or ab-
sence of the inhibitors wortmannin (W) or Ly294002 (LY). Nico-
tinamide (NIC), a potent inducer of endocrine cell differentiation,
was also included in some cultures. Insulin content (A) and insulin
release (B) were measured. *P , 0.05, **P , 0.005, ***P , 0.0005;
n 5 8.The Journal of Cell Biology, Volume 137, 1997 1132
Figure 3. Increased frequency of endocrine-positive cells and endocrine precursors in PI3K inhibitor–treated fetal islet cultures. Repre-
sentative fields, collected by confocal microscopy, are shown for control and Ly294002-treated ICCs. Immunoreactivity for insulin is
shown in red, somatostatin and pp in green, and glucagon in blue. Bar graphs represent the morphometric analysis of endocrine cell fre-
quency for each hormone and show the immunoreactive surface area expressed as percent of total surface area of ICCs. Notably, the en-
docrine surface area is significantly increased for all hormones in Ly294002-treated ICCs (insulin, P , 0.01; somatostatin and pp, P ,
0.03; glucagon, P , 0.03; n 5 3). When the three fluorescence spectra are merged (lower panels) to measure the total endocrine cell sur-
face, hormone colocalization can also be appreciated. Insulin and glucagon coexpression is highlighted by the appearance of a purple
color (arrowheads) resulting from the overlap of red and blue, whereas colocalization of insulin and somatostatin or pp is shown by the
yellow color (arrow) resulting from the overlap of red and green fluorescences. Note that the frequency of cells coexpressing multiple
hormones is increased in Ly294002-treated ICCs: seven cells coexpressing insulin and glucagon (purple) and two cells coexpressing insu-
lin and somatostatin or pp (yellow). Morphometric analysis demonstrates that the total endocrine cell surface area is significantly in-
creased in Ly294002-treated ICCs (lower right bar graph). Control sections incubated with irrelevant primary antibodies did not show
any detectable immunoreactivity (left panels). Bar, 12 mm.Ptasznik et al. PI3-Kinase and Cellular Differentiation 1133
tion signals at the cell surface of endocrine precursors to
transcriptional responses in the nucleus. We demonstrate
a previously unrecognized function for PI3K—as a nega-
tive regulator of endocrine differentiation in developing
mammalian cells. Blockade of PI3K activity in primary cul-
tured fetal pancreatic cells resulted in a robust activation
of endocrine differentiation. Treatment of ICCs with PI3K
inhibitors increased transcription of islet-specific hormone
genes, expression of islet-specific hormone proteins, insu-
lin content, insulin release in response to secretagogues,
the total number of endocrine-positive cells developing
in islets, and the number of precursor islet cells coexpress-
ing multiple hormones. By contrast, DNA synthesis was
significantly decreased in the PI3K inhibitor–treated islet
cells, as compared to untreated cells. However, inhibition of
DNA synthesis by serum starvation or by treatment with
cell cycle–blocking antibiotics had no effect on islet-spe-
cific hormone expression. This implies that the observed
effects are not secondary to nonspecific blockade of the
cell cycle, but they can be attributed directly to specific in-
hibition of PI3K. As a further indication of the involve-
ment of PI3K in regulating endocrine differentiation, we
also observed that the activity of this enzyme was inversely
correlated with the HGF/SF-induced downregulation or
NIC-induced upregulation of islet-specific hormone gene
expression, providing support for the role of PI3K as a
negative regulator of endocrine differentiation.
The basis for the interaction of cytoplasmic phospho-
lipid messengers with transcriptional factors in the nucleus
is, at present, unknown. Only a few potential biochemical
targets of phosphoinositides have been found in mamma-
lian cells (for review see Carpenter and Cantley, 1996). The
exact role and immediate downstream molecular targets of
PtdIns(3,4)P2 and PtdIns(3,4,5)P3 have not been identi-
fied. This is accurate for all known cellular functions of
PI3K in various systems. Thus, the precise molecular
mechanisms that link the inhibition of the PI3K to the in-
duction of endocrine differentiation remain to be eluci-
dated. It has been reported that proteins of the jun family
can inhibit islet-specific hormone gene transcription both
in vivo (Inagaki et al., 1992) and in vitro (Henderson and
Stein, 1994). The jun transcription factors block activity of
these genes through the E-box elements, which are com-
mon for insulin, glucagon, and somatostatin (Kruse et al.,
1993; Cordier-Bussat et al., 1995). The known ability of
PI3K to activate ras and subsequently the MAPK-Jun cas-
cade (Pulverer et al., 1991; Thomas et al., 1992; Hu et al.,
1995) provides a potentially direct link between PI3K sig-
naling and the inhibition of islet-specific hormone gene ex-
pression. This scenario would explain why treatment with
PI3K inhibitors can release the blockade of all islet-spe-
cific hormone genes, which is described in the present ex-
periments. Alternatively, it is possible that the functional
association of PI3K with the islet-specific hormone genes
is mediated by protein kinase C (PKC)-dependent path-
ways. Several recent reports have indicated that PI3K
might activate PKC isoforms both in vitro and in vivo (Na-
kanishi et al., 1993; Toker et al., 1994). PKC-dependent
branches of signal transduction pathways are known as up-
stream regulators of several regulatory genes and tran-
scription factors, including members of the c-rel family
(NF-kB), as well as members of the fos/jun family involv-
ing AP-1 sites (Leonardo and Baltimore, 1989; De Tata et
al., 1993). PKC was previously suggested to be involved in
intracellular control of insulin anabolism and secretion
(for review see Newgard and McGarry, 1995). Thus, the
PI3K could modify islet-specific gene expression in a PKC-
dependent manner. Another explanation for our results
would have to imply that PI3K can control biosynthesis
of transcriptional factors for hormone gene expression
during fetal neogenesis. We have recently shown that
Figure 4. Inhibition of proliferation in fetal islet cells by PI3K in-
hibitors. (A) Effect of PI3K inhibitors on [3H]thymidine incorpo-
ration into DNA. ICCs were cultured as described in Fig. 2.
[3H]thymidine (1 mCi/ml) was added to the cultures 16 h before
the assay. Data are combined from three independent experi-
ments and are presented as percentage of control ICCs from each
experiment. (Absolute control values were 2086 6 172, 4552 6
583, and 7625 6 536 cpm/mg DNA). *P , 0.05 compared to con-
trol, **P , 0.05 compared to treatment with nicotinamide or
wortmannin. Inhibition of DNA synthesis by mitomycin C or se-
rum starvation does not affect insulin protein expression in fetal
ICCs. ICCs were cultured in the presence of 2 mg/ml mitomycin C
for 5 d (B) or starved in 0.5% FBS for 2 d (C). Subsequently,
[3H]thymidine incorporation and insulin protein content were
measured as described in Materials and Methods.The Journal of Cell Biology, Volume 137, 1997 1134
phosphoinositides may regulate the expression of islet/
duodenum homeobox-1 (IDX-1) transcriptional factor in
undifferentiated rat insulinoma cells growing in vitro at low
passages (Ptasznik, A., unpublished data). IDX-1 (PDX-1,
IPF-1, STF-1) is known to be important for activation of
islet-specific genes and development of endocrine pan-
creas (Josson et al., 1994; Miller et al., 1994; Watada et al.,
1996). Experiments to test this alternative in primary
growing human fetal cells are in progress.
The data presented here strongly suggest that the func-
tional association between PI3K activity and islet-specific
gene expression is part of a more general developmental
program that coordinates cell differentiation and cell divi-
sion. It has previously been suggested that the general
function of HGF/SF is to allow various epithelial cells to
rearrange during embryogenesis by promoting their prolif-
eration, scattering, and invasiveness (Brinkmann et al.,
1995). The ability of PI3K to inhibit islet-specific hormone
gene expression, which we show in our present experi-
ments, provides an explanation for the link between the
activation of the HGF/SF receptor and the downregula-
tion of islet-specific gene transcription. Since PI3K is acti-
vated in islet cells by HGF/SF (Figs. 5 and 6), it could
serve in these proliferating cells at the same time to block
insulin synthesis and secretion. We have clearly shown that
induction of endocrine differentiation by PI3K inhibitors
is associated with a decrease in DNA synthesis in ICCs
(Figs. 1, 2, 3, 4) and, vice versa, that the transition of fetal
ICCs towards proliferation, by the addition of HGF/SF, is
associated with downregulation of islet-specific hormone
gene expression and a decrease in the hormone protein
content (Beattie et al., 1996a; Otonkoski et al., 1996). Thus,
according to our present results, it is possible to suggest
that PI3K may functionally convert activation of growth
factor receptors into downregulation of tissue-specific genes,
and in this way accommodate the rates of differentiation
versus proliferation in developing tissues. Thus, cell differ-
entiation and cell division would be modulated in a coordi-
nated way, by the common signaling transducer-PI3K. An
inverse relationship between proliferation and endocrine
differentiation in insulin-producing cells has already been
demonstrated previously (Philippe et al., 1987a,b; Oberg et
al., 1994). Our observation is also in agreement with the
general view that tissue-specific functions inversely corre-
late with cellular growth during embryogenesis.
It is known that external stimulation of islet cells with
insulin inhibits insulin gene expression in these cells (Ko-
ranyi et al., 1992). Consistent with our present results, it
is possible to suggest that PI3K, which is known to be a
downstream target for the insulin receptor (Backer et al.,
1993), might functionally link activation of this receptor to
downregulation of insulin and other hormone-specific genes
in fetal islet cells. This is also consistent with the recent
observation that islet b-cells express the insulin receptor
mRNA and insulin receptor substrate 1, i.e., the same sig-
nal transducers that are known to mediate insulin action in
peripheral insulin target tissues (Harbeck et al., 1996).
Since PI3K is activated by insulin in target tissues, it could
serve in b-cells at the same time to block insulin biosyn-
thesis and secretion. An autocrine feedback loop acting
through PI3K would be part of the signaling mechanism
maintaining homeostatic control within developing fetal
cells.
It has been shown that during development, multipoten-
tial epithelial stem cells give rise to all islet cell phenotypes
(Teitelman and Lee, 1987; Alpert et al., 1988). The double
control mechanism was suggested to be necessary during
islet development (Alpert et al., 1988; Herrera et al., 1991;
Figure 5. HGF/SF-induced increase of
PI3K activity in fetal ICCs. ICCs starved
for 24 h were stimulated for the indi-
cated times with HGF/SF (25 ng/ml).
Equivalent amounts of cell lysates were
immunoprecipitated with antiphospho-
tyrosine antibody (Upstate Biotechnol-
ogy, Inc.), and immune complexes were
assayed for PI3K activity as described in
Materials and Methods. The position of
migration of phosphatidylinositol 3
phosphate [PI(3)P] is indicated. Results
shown are representative of two inde-
pendent experiments.
Figure 6. Effect of continu-
ous treatment for 5 d with
HGF/SF or NIC on PIP3 for-
mation in fetal ICCs. (A) Au-
toradiogram of a thin-layer
chromatographic separation
of cell phospholipids showing
levels of PIP3 in fetal islet
cells treated continuously
for 5 d in the absence (Cont)
or presence of 25 ng/ml
HGF/SF (HGF) or 10 mM
nicotinamide (NIC). (B) Ra-
dioactivity in PIP3 spots was
quantitated and is expressed
relative to control. Results
shown are representative of
three similar experiments.
PA, phosphatidic acid; PC,
phosphatidylcholine.Ptasznik et al. PI3-Kinase and Cellular Differentiation 1135
Cordier-Bussat et al., 1995). The first step occurs when all
the islet-specific hormone genes are activated, and the
cells are able to coexpress multiple hormone genes. The
second step occurs when the differentiating cells become
restricted to express only one hormone gene. The data pre-
sented here strongly point to the early islet progenitor
cells as a target, which responded to our treatment with
PI3K inhibitors. Thus, we observed that treatment with
these inhibitors released the blockade of all hormone
genes in undifferentiated pancreatic cells and significantly
increased the number of cells coexpressing multiple hor-
mone proteins, which are known to represent precursors
of terminally differentiated islet cells. As a further indi-
cation of the involvement of progenitor islet cells, we also
observed that the PI3K inhibitors combined with NIC
caused the synergistic increase of the mRNA levels of is-
let-specific hormone genes. NIC alone was previously shown
to induce these mRNA levels only in precursor cells, with-
out any effect on mature endocrine islet cells (Otonkoski
et al., 1993). Finally, we observed no effect of PI3K inhibi-
tors or NIC on endocrine function in purified fetal islets
(data not shown). These results would suggest, again, that
the effects that we found in primary cultured ICCs, rich in
precursor cells, were developmentally dependent. For this
reason, these effects cannot be detected in purified islets,
which contain mostly terminally differentiated endocrine
cells and few precursor cells (see Materials and Methods).
In conclusion, our results describe a role of PI3K in reg-
ulating development of the human endocrine system. In-
terestingly, it was shown just recently that inhibition of the
PI3K displays a stimulatory effect on melanogenesis and
dendrite outgrowth in B16 murine melanoma cell line
(Busca et al., 1996). Thus, the negative regulation of cellu-
lar differentiation by PI3K, which we independently dis-
covered in primary growing human cells during fetal neo-
genesis, may be a general phenomenon. Nevertheless,
other authors have previously shown a positive involve-
ment of PI3K in PC12 pheochromocytoma and 3T3-
F442A adipocytic cell lines differentiation (Hempstead et
al., 1992; Kimura et al., 1994; Saad et al., 1994). Taken to-
gether, all available results suggest that the PI3K may play
a dual role as both a positive and negative regulator of cel-
lular differentiation in mammalian cells. Future studies di-
rected at the downstream signaling elements coupled to
PI3K should prove informative, as will further investiga-
tion of the transcriptional factors by which PI3K links to
tissue-specific gene regulation.
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